How analysts are interpreting Biogen's management shakeup
June 14, 2017 at 13:03 PM EDT
The Cambridge drugmaker has lost several top executives since getting a new CEO in January, hinting that bigger changes could be afoot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.